Alvogen

Alvogen

Alvogen is a privately owned US-based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products. Alvogen’s Teriparatide Injection is the first FDA-approved teriparatide alternative to Forteo®*. Teriparatide Injection delivers proven clinical experience and affordability to help your patients at high risk for fracture increase bone density.
* Not automatically substituted for Forteo.

Pharmaceutical